Bit Capital Gmb H Kezar Life Sciences, Inc. Transaction History

Bit Capital Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Feb 12, 2025	SELL	$3.13 - $7.31 $345,458 - $806,804	-110,370 Closed	0 $0
Q4 2022 Feb 12, 2025	BUY	$6.39 - $8.8 $269,095 - $370,585	42,112 Added 61.7%	110,370 $786 Million
Q3 2022 Feb 12, 2025	BUY	$7.99 - $10.75 $220,188 - $296,248	27,558 Added 67.71%	68,258 $588 Million
Q2 2022 Feb 12, 2025	SELL	$4.58 - $17.13 $146,789 - $549,016	-32,050 Reduced 44.05%	40,700 $356 Million
Q1 2022 Feb 12, 2025	SELL	$12.3 - $18.33 $458,175 - $682,792	-37,250 Reduced 33.86%	72,750 $1.2 Billion
Q4 2021 Feb 12, 2025	BUY	$7.44 - $16.72 $818,400 - $1.84 Million	110,000 New	110,000 $1.44 Billion

30.6M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $417M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.